Edition:
India

Ion Beam Applications SA (IBAB.BR)

IBAB.BR on Brussels Stock Exchange

23.50EUR
19 Jan 2018
Change (% chg)

€0.18 (+0.77%)
Prev Close
€23.32
Open
€23.30
Day's High
€23.50
Day's Low
€21.60
Volume
209,710
Avg. Vol
118,807
52-wk High
€56.94
52-wk Low
€15.80

Latest Key Developments (Source: Significant Developments)

Ion Beam Applications Signed Contract With Invap For Additional Gantry Treatment Room
Friday, 5 Jan 2018 

Jan 5 (Reuters) - ION BEAM APPLICATIONS SA ::SIGNED NEW CONTRACT WITH INVAP FOR ADDITIONAL GANTRY TREATMENT ROOM AT CNEA.NEW EQUIPMENT ORDER HAS BEEN BOOKED IN 2017 AND IS WORTH BETWEEN EUR 10 AND 15 MILLION TO IBA, INCLUDING A MULTI-YEAR SERVICE AGREEMENT.IBA EXPECTS TO RECEIVE A DOWN PAYMENT FOR THIS NEW CONTRACT IN COMING WEEKS.  Full Article

Ion Beam Applications Says Won't Meet Previous FY 2017 Revenue Guidance And Will Report A Negative Rebit
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Ion Beam Applications Sa ::IS FINALIZING LATE STAGE NEGOTIATIONS FOR CONTRACTS WITH AT LEAST FOUR PROTON THERAPY PROSPECTS THAT HAD BEEN EXPECTED TO BE SIGNED IN 2017.CONTINUES TO BE CONFIDENT IN SIGNING THESE CONTRACTS.COMPANY WILL NOT MEET ITS PREVIOUSLY ANNOUNCED FULL YEAR 2017 REVENUE GUIDANCE AND WILL REPORT A NEGATIVE REBIT.EXPECTS TO RETURN TO A POSITIVE REBIT AND NET PROFIT AFTER TAX IN 2018.IS WITHDRAWING ALL OTHER GUIDANCE UNTIL FURTHER NOTICE.  Full Article

IBA 9-month revenues at 217.3 million euros, down 3.6% ‍​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - ION BEAM APPLICATIONS SA ::9M REVENUES TO 30 SEPTEMBER 2017 OF EUR 217.3 MILLION, DOWN 3.6% ‍​.‍PROTON THERAPY AND OTHER ACCELERATORS ORDERS AT END OF Q3 TOTALLING EUR 76.7 MILLION​.EXPECTS FY17: 5-10% REVENUE GROWTH AND A 0-5% REBIT MARGIN.EXPECTS 2018/2019: 0-5% REVENUE GROWTH AND A 5-10% REBIT MARGIN.EXPECTS 2020 ONWARDS: 5-10% REVENUE GROWTH AND 13-15% REBIT MARGIN..DIVIDEND POLICY REMAINS UNCHANGED..‍REITERATES ITS GUIDANCE GIVEN AT TIME OF ITS HALF YEAR 2017 RESULTS​.DOSIMETRY BACKLOG AT END OF Q3 2017 WAS AT EUR 15.4 MILLION.DOSIMETRY ORDER INTAKE REMAINED STRONG AT EUR 39.4 MILLION AT END OF Q3 2017.NET NEGATIVE CASH POSITION OF EUR 2.5 MILLION AT END OF Q3 VERSUS POSITIVE NET CASH POSITION OF EUR 36.1 MILLION YEAR AGO‍​.  Full Article

IBA signs global construction collaboration with Vinci
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - ION BEAM APPLICATIONS SA ::IBA SIGNS GLOBAL CONSTRUCTION COLLABORATION WITH VINCI.‍FINANCIAL TERMS OF COLLABORATION ARE NOT DISCLOSED​.VINCI CONSTRUCTION WILL LEAD IN THE DESIGN OF THE BUILDING AND RELATED TECHNICAL ELEMENTS‍​.IBA WILL RETAIN LEAD OF THE DESIGN OF THE PROTON/CARBON THERAPY EQUIPMENT.  Full Article

Ion Beam Applications signs two contracts with Proton Partners International
Tuesday, 13 Dec 2016 

Ion Beam Applications SA : Typical end-user price for a Proteus ONE solution with a maintenance contract is between 35 million euros ($37.21 million) and 40 million euros .IBA signs two new Proteus ONE contracts with Proton Partners International.  Full Article

IBA signs contract to install Proteus One compact proton therapy center in Abu Dhabi
Tuesday, 27 Sep 2016 

Ion Beam Applications SA :Signs contract to install Proteus One compact proton therapy center in Abu Dhabi, UAE.  Full Article

IBA signs contract with Medstar for the purchase of a proton therapy system
Monday, 26 Sep 2016 

Ion Beam Applications SA :Announced on Sunday that it signed a contract with Medstar (Shanghai) Leasing Co., Ltd, a subsidiary of Concord Medical Services Holdings Limited, for the purchase, installation and maintenance of a proton therapy system.  Full Article

Ion Beam Applications H1 net profit down at 8.3‍​ million euros
Thursday, 25 Aug 2016 

Ion Beam Applications SA : H1 revenue 145.1‍​ million euros versus 121.0 million euros ($136.39 million) year ago . H1 rebitda 18.0‍​ million euros versus 14.6 million euros year ago .H1 net income 8.3‍​ million euros versus 14.5 million euros year ago.  Full Article

IBA invests 2 million US dollars in HIL Applied Medical Ltd.
Tuesday, 23 Aug 2016 

Ion Beam Applications SA : ‍​IBA invests in HIL Applied Medical Ltd. to develop laser-based proton therapy system .IBA has invested USD 2 million and is leading HIL’s series C round, together with other investors.  Full Article

IBA wins 80 mln euro plus contract in China
Wednesday, 29 Jun 2016 

Ion Beam Applications SA : Signs contract to install proton therapy center in China . Contract worth more than 80 million euros ($88.5 million) and includes a long term service contract . IBA will equip the new center with five treatment rooms, four isocentric-gantry treatment rooms and a fixed-beam treatment room .Qingdao Zhong Jia Lian He Healthcare Management Company Ltd expects to be treating patients at the center by the end of 2018.  Full Article

Proton therapy firm IBA sees operating loss due to contract delays

Jan 5 Belgian proton therapy specialist Ion Beam Applications (IBA) warned on Friday it expected to report a full-year operating loss due to delays in negotiations to sign proton therapy contracts.